I

InSilico Medicine Cayman TopCo
OTC:ISLMF

Watchlist Manager
InSilico Medicine Cayman TopCo
OTC:ISLMF
Watchlist
Price: 5.5 USD -8.33%
Market Cap: $3.1B

Wall St Price Targets

ISLMF Price Targets Summary
InSilico Medicine Cayman TopCo

Wall Street analysts forecast ISLMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ISLMF is 10.77 USD with a low forecast of 10.47 USD and a high forecast of 11.3 USD.

Lowest Forecast
Price Target
10.47 USD
90% Upside
Average Forecast
Price Target
10.77 USD
96% Upside
Highest Forecast
Price Target
11.3 USD
105% Upside
InSilico Medicine Cayman TopCo Competitors:
Price Targets
SKE
Skeena Resources Ltd
33% Upside
WW
WW International Inc
69% Upside
ACCON
Acconeer AB
-69% Downside

Revenue
Forecast

-34% / Year
Past Growth
65% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-34% / Year
Past Growth
65% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been -34%. The projected CAGR for the next 3 years is 65%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ISLMF's stock price target?
Price Target
10.77 USD

According to Wall Street analysts, the average 1-year price target for ISLMF is 10.77 USD with a low forecast of 10.47 USD and a high forecast of 11.3 USD.

What is the Revenue forecast for InSilico Medicine Cayman TopCo?
Projected CAGR
65%

Over the last 1 year, the compound annual growth rate for Revenue has been -34%. The projected CAGR for the next 3 years is 65%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett